-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDSConnectPilotFinalReport508gel10012018.pdf
September 01, 2018 - The primary objective of the
pilot is to demonstrate the feasibility of implementing an evidence-based … Pilot Goals and Scope
The primary … The primary reason cited was the lag time experienced by the clinicians in the launch of the
Summary … tagged PDF
Logical Reading Order Passed manually Document structure provides a logical reading order
Primary
-
cds.ahrq.gov/taxonomy/term/70931
July 05, 2022 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/taxonomy/term/138156
February 16, 2024 - Search All AHRQ Sites
Careers
Contact Us
Español
FAQs
Email Updates
-
cds.ahrq.gov/sites/default/files/cds/artifact/76/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Shared%20Decision%20Making.pdf
April 01, 2021 - Year ASCVD risk score for an individual to help when considering initiating or optimizing
therapy for primary … are primarily for use by clinicians
and patients performing assessment and treatment planning in a primary
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax%20Post%20Exposure%20Prophylaxis%20Implementation%20Guide%20v2.0%2020190607.pdf
June 07, 2019 - Statement ..................................................................................4
2.3 Primary … BioThrax (anthrax vaccine) for persons who have
completed a pre-exposure vaccination series.
2.3 Primary … Use Cases
In the primary use case, the CDS artifact is intended for use by clinicians delivering care
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pain%20Management%20Summary%20Clincial%20Decision%20Support%20Toolkit_for%20Repository_0.xlsx
January 01, 2003 - 245346 Aluminum Hydroxide 100 MG/ML / Magnesium Hydroxide 100 MG/ML Oral Suspension
G47.31 Primary … elsewhere classified
K74.69 Other cirrhosis of liver
K76.6 Portal hypertension
K74.3 Primary
-
cds.ahrq.gov/sites/default/files/cds/artifact/81/CMSs%20Million%20Hearts%20Model%20Longitudinal%20ASCVD%20Risk%20Assessment%20Tool%20for%20Updated%2010-Year%20ASCVD%20Risk.pdf
January 01, 2010 - are
primarily for use by clinicians and patients performing assessment and treatment planning in a
primary
-
cds.ahrq.gov/sites/default/files/cds/artifact/711/Anthrax_Post_Exposure_Prophylaxis_CDS_Validation_Report.pdf
October 17, 2018 - Synthea™ comes with a
growing set of modules, including models for the top 10 reasons patients visit a primary